Dr. Naveed Aslam, a 52-year-old oncologist from West Bloomfield, was sentenced to 18 months in federal prison for participating in a multi-million-dollar scheme to divert and illegally sell high-cost prescription cancer drugs. U.S. District Judge Brandy R. McMillion handed down the sentence after Aslam pleaded guilty.
Judge McMillion also ordered Aslam to forfeit more than $2.6 million—the amount he earned from the scheme.
The announcement came from U.S. Attorney Jerome F. Gorgon, Jr., joined by officials from HHS-OIG, the FBI, Homeland Security Investigations, and the FDA.
Court documents show that between 2019 and 2023, Aslam and several co-conspirators purchased and distributed expensive cancer drugs outside the legal supply chain. Aslam, who practiced at Somerset Hematology and Oncology, P.C., used his medical credentials to order the medications, which were then sold to a co-conspirators’ company for profit.
The group targeted customers seeking specialized cancer treatments—medications that Aslam was authorized to use only within his medical practice and was legally prohibited from selling.
The diverted drugs—used to treat metastatic cervical, breast, bladder, and urinary tract cancers—are highly toxic and require strict handling protocols. Over four years, Aslam obtained and resold more than $17 million worth of these medications, personally collecting more than $2.6 million.
Although investigators found no evidence that patients were harmed, federal officials emphasized that the scheme created substantial safety risks for vulnerable patients relying on these critical treatments.
Leave a Reply